Onconetix, Inc.
ONCO
$4.00
-$0.10-2.44%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -85.73% | 74.98% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -85.73% | 74.98% | |||
| Cost of Revenue | 7.31% | -82.75% | |||
| Gross Profit | -93.06% | 526.19% | |||
| SG&A Expenses | 287.28% | -83.64% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 262.43% | -84.14% | |||
| Operating Income | -825.23% | 108.61% | |||
| Income Before Tax | 71.85% | -681.61% | |||
| Income Tax Expenses | -- | -1,527.66% | |||
| Earnings from Continuing Operations | 70.97% | -669.15% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 70.97% | -669.15% | |||
| EBIT | -825.23% | 108.61% | |||
| EBITDA | -574.68% | 114.22% | |||
| EPS Basic | 84.56% | -16.78% | |||
| Normalized Basic EPS | -167.18% | 106.77% | |||
| EPS Diluted | 84.56% | -16.78% | |||
| Normalized Diluted EPS | -167.18% | 106.77% | |||
| Average Basic Shares Outstanding | 112.31% | -92.38% | |||
| Average Diluted Shares Outstanding | 112.31% | -92.38% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||